180 related articles for article (PubMed ID: 27805735)
1. Carvedilol and antioxidant proteins in a type I diabetes animal model.
Diogo CV; Deus CM; Lebiedzinska-Arciszewska M; Wojtala A; Wieckowski MR; Oliveira PJ
Eur J Clin Invest; 2017 Jan; 47(1):19-29. PubMed ID: 27805735
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress.
Carreira R; Duarte A; Monteiro P; Santos MS; Rego AC; Oliveira CR; Gonçalves LM; Providência LA
Rev Port Cardiol; 2004 Nov; 23(11):1447-55. PubMed ID: 15693697
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol protected diabetic rat hearts via reducing oxidative stress.
Huang H; Shan J; Pan XH; Wang HP; Qian LB
J Zhejiang Univ Sci B; 2006 Sep; 7(9):725-31. PubMed ID: 16909474
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol improved diabetic rat cardiac function depending on antioxidant ability.
Huang H; Shan J; Pan XH; Wang HP; Qian LB; Xia Q
Diabetes Res Clin Pract; 2007 Jan; 75(1):7-13. PubMed ID: 16780994
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats.
Prakash AK; Kumar A
J Pharm Pharmacol; 2009 Dec; 61(12):1665-72. PubMed ID: 19958590
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells.
Sgobbo P; Pacelli C; Grattagliano I; Villani G; Cocco T
Biochim Biophys Acta; 2007 Mar; 1767(3):222-32. PubMed ID: 17346667
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
Santos DJ; Moreno AJ
Biochem Pharmacol; 2001 Jan; 61(2):155-64. PubMed ID: 11163330
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.
Fu GS; Huang H; Chen F; Wang HP; Qian LB; Ke XY; Xia Q
Eur J Pharmacol; 2007 Jul; 567(3):223-30. PubMed ID: 17559835
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage.
Hamdy N; El-Demerdash E
Toxicol Appl Pharmacol; 2012 Jun; 261(3):292-9. PubMed ID: 22543095
[TBL] [Abstract][Full Text] [Related]
12. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury.
Oliveira PJ; Rolo AP; Palmeira CM; Moreno AJ
Cardiovasc Toxicol; 2001; 1(3):205-13. PubMed ID: 12213973
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism.
Oliveira PJ; Esteves T; Rolo AP; Palmeira CM; Moreno AJ
Cardiovasc Toxicol; 2004; 4(1):11-20. PubMed ID: 15034201
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat.
Kumar A; Dogra S
Pharmacol Biochem Behav; 2009 Mar; 92(1):25-31. PubMed ID: 18992766
[TBL] [Abstract][Full Text] [Related]
16. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?
Oliveira PJ; Gonçalves L; Monteiro P; Providencia LA; Moreno AJ
Curr Vasc Pharmacol; 2005 Apr; 3(2):147-58. PubMed ID: 15853634
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.
Rodrigues MA; Rodrigues JL; Martins NM; Barbosa F; Curti C; Santos NA; Santos AC
Chem Biol Interact; 2011 Jan; 189(1-2):45-51. PubMed ID: 21044617
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol attenuates oxidative stress in chronic chagasic cardiomyopathy.
Budni P; Pedrosa RC; Garlet TR; Dalmarco EM; Dalmarco JB; Lino MR; Simionato EL; Amara JA; Frode TS; Wilhelm Filho D
Arq Bras Cardiol; 2012 Mar; 98(3):218-24. PubMed ID: 22344676
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of testicular protection of carvedilol in streptozotocin-induced diabetic rats.
Ramzy MM; El-Sheikh AA; Kamel MY; Abdelwahab SA; Morsy MA
Indian J Pharmacol; 2014; 46(2):161-5. PubMed ID: 24741186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
